Citadel Advisors »

Mink Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $181k 15k 11.69

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Mink Therapeutics

Vanguard Capital Management
DnB NOR Asset Management AS
Longbow Finance SA
Geode Capital Management
Citadel Advisors
BlackRock
Vanguard Fiduciary Trust
UBS Group
Steward Partners Investment Advisory
Us Bancorp
Paladin Partners
Federation des caisses Desjardins du Quebec
Tower Research Capital
Covestor
Advisor Group Holdings

View all funds holding Mink Therapeutics